Mutations in <i>CIC</i> and <i>FUBP1</i> Contribute to Human Oligodendroglioma

Chetan Bettegowda(Howard Hughes Medical Institute), Nishant Agrawal(Howard Hughes Medical Institute), Yuchen Jiao(Howard Hughes Medical Institute), Mark Sausen(Howard Hughes Medical Institute), Laura D. Wood(Johns Hopkins University), Ralph H. Hruban(Johns Hopkins University), Fausto J. Rodríguez(Johns Hopkins University), Daniel P. Cahill(The University of Texas MD Anderson Cancer Center), Roger E. McLendon(Pediatric Brain Tumor Foundation), Gregory J. Riggins(Howard Hughes Medical Institute), Victor E. Velculescu(Howard Hughes Medical Institute), Sueli Mieko Oba‐Shinjo(Universidade de São Paulo), Suely Kazue Nagahashi Marie(Universidade de São Paulo), Bert Vogelstein(Howard Hughes Medical Institute), Darell D. Bigner(Pediatric Brain Tumor Foundation), Hai Yan(Pediatric Brain Tumor Foundation), Nickolas Papadopoulos(Howard Hughes Medical Institute), Kenneth W. Kinzler(Howard Hughes Medical Institute)
Science
August 4, 2011
Cited by 552

Abstract

Oligodendrogliomas are the second most common malignant brain tumor in adults and exhibit characteristic losses of chromosomes 1p and 19q. To identify the molecular genetic basis for this alteration, we performed exomic sequencing of seven tumors. Among other changes, we found that the CIC gene (homolog of the Drosophila gene capicua) on chromosome 19q was somatically mutated in six cases and that the FUBP1 gene [encoding far-upstream element (FUSE) binding protein] on chromosome 1p was somatically mutated in two tumors. Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins. These results suggest a critical role for these genes in the biology and pathology of oligodendrocytes.


Related Papers

No related papers found

Powered by citation graph analysis